A new poll recently published by health policy research firm KFF revealed that roughly 12% of U.S. adults (or one in eight) have taken GLP-1 drugs, a category that includes Wegovy, Ozempic, Zepbound, ...
Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, according to the latest edition of Trinity Life Sciences’ annual Drug Index—a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results